Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

What is known about the nausea reported in BYETTA clinical trials?

April 26, 2017BYETTA clinical trials known nausea reported

0

Posted

What is known about the nausea reported in BYETTA clinical trials?

1 Answer

0

Posted

In clinical trials, nausea was mostly mild to moderate and it occurred most commonly upon initiation of therapy. Of BYETTA-treated patients, 3% withdrew due to nausea over the course of the entire 30-week clinical trials. Initiation of BYETTA at 5 mcg BID for at least a month followed by dose escalation to 10 mcg BID has been found to minimize the occurrence of nausea.